260 related articles for article (PubMed ID: 1331510)
1. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
[TBL] [Abstract][Full Text] [Related]
2. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.
Yoshimura FK; Diem K; Chen H; Tupper J
J Virol; 1993 Apr; 67(4):2298-304. PubMed ID: 8383242
[TBL] [Abstract][Full Text] [Related]
3. Sequences between the enhancer and promoter in the long terminal repeat affect murine leukemia virus pathogenicity and replication in the thymus.
Yoshimura FK; Wang T; Cankovic M
J Virol; 1999 Jun; 73(6):4890-8. PubMed ID: 10233950
[TBL] [Abstract][Full Text] [Related]
4. Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities.
Chen H; Yoshimura FK
J Virol; 1994 May; 68(5):3308-16. PubMed ID: 8151791
[TBL] [Abstract][Full Text] [Related]
5. Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.
Yoshimura FK; Tupper J; Diem K
J Virol; 1989 Nov; 63(11):4945-8. PubMed ID: 2552174
[TBL] [Abstract][Full Text] [Related]
6. Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.
Hollon T; Yoshimura FK
J Virol; 1989 Aug; 63(8):3353-61. PubMed ID: 2545910
[TBL] [Abstract][Full Text] [Related]
7. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
Yoshimura FK; Wang T
Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
[TBL] [Abstract][Full Text] [Related]
8. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins.
Tanimura A; Teshima H; Fujisawa J; Yoshida M
J Virol; 1993 Sep; 67(9):5375-82. PubMed ID: 8350401
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional initiation and postinitiation effects of murine leukemia virus long terminal repeat R-region sequences.
Cupelli LA; Lenz J
J Virol; 1991 Dec; 65(12):6961-8. PubMed ID: 1658385
[TBL] [Abstract][Full Text] [Related]
10. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS
J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
[TBL] [Abstract][Full Text] [Related]
11. Negative regulatory element associated with potentially functional promoter and enhancer elements in the long terminal repeats of endogenous murine leukemia virus-related proviral sequences.
Ch'ang LY; Yang WK; Myer FE; Yang DM
J Virol; 1989 Jun; 63(6):2746-57. PubMed ID: 2542587
[TBL] [Abstract][Full Text] [Related]
12. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
DesGroseillers L; Jolicoeur P
J Virol; 1984 Nov; 52(2):448-56. PubMed ID: 6092670
[TBL] [Abstract][Full Text] [Related]
13. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
Lawrenz-Smith SC; Massey AC; Innes DJ; Thomas CY
J Virol; 1994 Aug; 68(8):5174-83. PubMed ID: 8035516
[TBL] [Abstract][Full Text] [Related]
16. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
17. AKR thymic lymphomas involving mink cell focus-inducing murine leukemia viruses have a common region of provirus integration.
Yoshimura FK; Levine KL
J Virol; 1983 Feb; 45(2):576-84. PubMed ID: 6300421
[TBL] [Abstract][Full Text] [Related]
18. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
[TBL] [Abstract][Full Text] [Related]
19. Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice.
Chinsky J; Goodenow MM; Jackson M; Lilly F; Leinwand L; Childs G
J Virol; 1985 Jan; 53(1):94-9. PubMed ID: 2981367
[TBL] [Abstract][Full Text] [Related]
20. Virological events leading to spontaneous AKR thymomas.
Stoye JP; Moroni C; Coffin JM
J Virol; 1991 Mar; 65(3):1273-85. PubMed ID: 1847454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
